China Genetic Testing Market

The China genetic testing market is experiencing rapid growth, driven by increasing demand for precision medicine, rising health awareness, and government support for biotechnology innovation. Next-generation sequencing (NGS) and non-invasive prenatal testing (NIPT) dominate the sector, with oncology and reproductive health as key applications. Domestic companies like BGI Genomics and Berry Genomics are expanding their market share, competing with global players through cost-effective solutions. Regulatory reforms are streamlining approvals, though data privacy concerns persist. Direct-to-consumer genetic testing is gaining popularity, particularly for ancestry and wellness insights. The market is also seeing advancements in AI-driven diagnostics, enhancing accuracy and efficiency in genetic analysis.

Read More: https://www.imarcgroup.com...